Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

13.2K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.2K
Protein Organization01:24

Protein Organization

7.0K
Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence....
7.0K
Molecular Models02:00

Molecular Models

40.3K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
40.3K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

895
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
895

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ProphDR: An Interpretable Deep Learning Model for Predicting Cancer Drug Response via Multi-Omics and Cross-Attention Mechanisms.

Journal of chemical information and modeling·2026
Same author

TPS-Flow: Physics-Guided Flow-Based Generative Modeling of Protein Transition Paths.

Journal of chemical information and modeling·2026
Same author

Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

Journal of medicinal chemistry·2026
Same author

AI decodes protein-ligand binding.

Nature chemical biology·2026
Same author

Generative AI for controllable protein sequence design: A survey.

npj drug discovery·2026
Same author

Unified heterogeneity-aware benchmark of drug synergy prediction: a cross-study analysis of traditional machine learning and graph deep learning models.

Journal of cheminformatics·2026

Related Experiment Video

Updated: Sep 7, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.7K

RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design.

Mingyang Wang1, Chang-Yu Hsieh2, Jike Wang1

  • 1Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou 310058, Zhejiang, P. R. China.

Journal of Medicinal Chemistry
|June 17, 2022
PubMed
Summary

This study introduces RELATION, a novel 3D deep learning model for de novo molecular design. It effectively generates new drug candidates by considering protein binding pocket geometry, improving drug discovery.

More Related Videos

Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

10.1K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

326

Related Experiment Videos

Last Updated: Sep 7, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.7K
Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

10.1K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

326

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Artificial intelligence in medicine

Background:

  • Deep learning (DL) models are increasingly used for de novo molecular design.
  • Existing DL models primarily focus on ligands, underutilizing target binding pocket 3D geometry.
  • Integrating 3D structural information is crucial for designing effective and targeted molecules.

Purpose of the Study:

  • To develop a novel 3D-based generative model for de novo molecular design.
  • To leverage protein-ligand complex geometry in the molecular generation process.
  • To design novel molecules with specific geometric properties and pharmacophore features.

Main Methods:

  • Proposed the RELATION (REpresentation LEarning and ANalysis) model for 3D-based molecular generation.
  • Developed the BiTL (Binding-aware Transfer Learning) algorithm to encode geometric features into a latent space.
  • Employed pharmacophore conditioning and docking-based Bayesian sampling for efficient chemical space navigation.

Main Results:

  • The RELATION model successfully generated novel molecular inhibitors for AKT1 and CDK2 targets.
  • Generated molecules exhibited favorable predicted binding affinity and essential pharmacophore features.
  • The model demonstrated efficient navigation of chemical space guided by 3D structural information.

Conclusions:

  • The RELATION model represents a significant advancement in 3D-based de novo molecular design.
  • Incorporating binding pocket geometry enhances the generation of targeted and effective drug candidates.
  • This approach holds promise for accelerating the discovery of novel therapeutics.